STOCK TITAN

Mirion Technologies (MIR) Stock News, Feb-Jul 2022

MIR NYSE

Mirion Technologies, Inc. reports company developments in radiation detection, measurement, analysis and monitoring solutions for nuclear, medical, defense and research markets. Updates commonly cover financial results, orders, guidance, investor presentations and leadership appointments across the Nuclear & Safety and Medical groups.

Mirion's recurring business themes include nuclear power customers, critical radiation safety applications, R&D labs, nuclear facilities and healthcare uses such as Nuclear Medicine, Radiation Therapy QA, Occupational Dosimetry and Diagnostic Imaging. News also reflects the completed Paragon Energy Solutions acquisition, which added engineered nuclear-power offerings and is being integrated into the Nuclear & Safety group.

Rhea-AI Summary

Mirion Technologies (NYSE: MIR) has announced the rebranding of its Medical segment to the Mirion Medical group, consolidating its healthcare-focused entities like Dosimetry Services and Sun Nuclear. This move aims to leverage expertise in ionizing radiation for healthcare applications, enhancing safety and efficiency for practitioners and patients. The new brand identity will feature a family logo, indicating unity among the different business units. This change will not affect how Mirion reports financial performance externally.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.99%
Tags
none
-
Rhea-AI Summary

Mirion Technologies, Inc. (NYSE: MIR) announced that CEO Thomas Logan and CFO Brian Schopfer will present at CJS Securities’ 22nd Annual “New Ideas” Summer Conference in Greenwich, CT, on Tuesday, July 12, 2022. Mirion is a leader in detection, measurement, and monitoring solutions for the nuclear, defense, medical, and research sectors, emphasizing regulatory compliance and operational excellence. The company is headquartered in Atlanta, GA, and employs approximately 2,600 individuals across 13 countries.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.37%
Tags
conferences
-
Rhea-AI Summary

Sun Nuclear Corporation, a subsidiary of Mirion Technologies (NYSE: MIR), will showcase its advanced quality management solutions for radiation therapy at the ESTRO 2022 Congress from May 6-10 in Copenhagen. Key highlights include the introduction of the SunSCAN™ 3D Cylindrical Water Scanning System, which enhances workflow efficiency and accuracy for stereotactic treatments. The SunCHECK™ Platform introduces a new SaaS option for easier deployment. Sun Nuclear also integrates CIRS technology for patient safety, with product demonstrations and educational sessions scheduled throughout the event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.14%
Tags
none
Rhea-AI Summary

Mirion Technologies, Inc. (NYSE: MIR) reported a 1.8% decrease in revenues for Q1 2022, totaling $163.2 million. The net loss improved to $19.0 million from $40.7 million year-over-year. Adjusted EBITDA fell 12.5% to $34.9 million. The company updated its 2022 guidance, forecasting organic adjusted revenue growth of 4%-6% and adjusted EBITDA of $170-$180 million. Despite challenges from supply chain issues and the Ukraine conflict, Mirion remains optimistic about its business strategy and order inflows.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.20%
Tags
-
Rhea-AI Summary

Mirion Technologies, Inc. (NYSE: MIR) announced the release of the SunSCAN™ 3D cylindrical water scanning system by its subsidiary Sun Nuclear Corporation.

The system improves radiation therapy workflows, offering hyper-accurate dosimetry with a precision of 0.1 mm for stereotactic treatments. It features faster setup times and new SunDOSE™ software for enhanced quality assurance.

Demonstrations will take place at the ESTRO 2022 conference from May 6-10 in Copenhagen, with an online release event on May 17.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.95%
Tags
none
-
Rhea-AI Summary

Mirion Technologies (NYSE: MIR) announced that CEO Thomas Logan and CFO Brian Schopfer will present at the Goldman Sachs Industrials and Materials Conference on May 10, 2022, at 11:20 AM ET in New York, NY. The presentation will be available for live streaming on their website, with an archived version accessible for two weeks after the event. Mirion Technologies specializes in detection and monitoring solutions across various sectors, including nuclear and defense, and operates in 13 countries.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.50%
Tags
conferences
Rhea-AI Summary

Mirion Technologies, Inc. (NYSE: MIR) announced that CEO Thomas Logan and CFO Brian Schopfer will present at Wells Fargo’s 2022 Industrials Conference on Thursday, May 5, 2022, at 12:00 PM ET in New York, NY.

The presentation will be webcast live and accessible at Mirion's website, where it will be archived for two weeks following the event. Mirion provides detection, measurement, analysis, and monitoring solutions across various sectors, employing around 2,600 people globally.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.43%
Tags
conferences
-
Rhea-AI Summary

Mirion Technologies (NYSE: MIR) will release its financial results for the first quarter of 2022 on May 4, 2022, followed by a conference call at 11:00 am ET. Participants can join by calling 1-844-826-3033 or 1-412-317-5185. A live webcast will also be available at Mirion's Investor page. A telephonic replay will be accessible until May 18, 2022. Mirion is a leader in detection, measurement, and analysis solutions for various markets, including nuclear and medical, employing around 2,600 people across 13 countries.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.58%
Tags
conferences earnings
-
Rhea-AI Summary

Mirion Technologies (NYSE: MIR) has announced an upgraded Cloud-hosted, SaaS option for its SunCHECK™ Quality Management Platform. This platform enhances workflows for Radiation Therapy Quality Assurance, improving patient safety and reducing operational burdens. The SaaS model offers better scalability and reliability, utilizing Amazon Web Services for infrastructure. Over 1,600 users currently utilize SunCHECK software, showcasing its significance in cancer care. The SaaS solution is designed to meet diverse clinic needs and will be demonstrated at ESTRO 2022 in Copenhagen.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.09%
Tags
none
Rhea-AI Summary

Mirion Technologies reported a 18% increase in revenue for Q4 2021, totaling $177.8 million, compared to $150.8 million in Q4 2020. The company posted a GAAP net loss of $23.0 million for the same period. Adjusted EBITDA rose to $44.5 million, up from $31.2 million in the previous quarter. For the fiscal year 2022, Mirion forecasts adjusted revenue growth between 5.5% and 7.5% and adjusted EBITDA of $175 million to $185 million. The company is facing supply chain challenges but remains confident in its growth prospects.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.05%
Tags

FAQ

What is the current stock price of Mirion Technologies (MIR)?

Mirion Technologies (MIR) last closed at $17.04.

What is the market cap of Mirion Technologies (MIR)?

The market cap of Mirion Technologies (MIR) is approximately $4.2B.